Biologics & Biosimilars Market Report

Global Biologics & Biosimilars Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 15, 2021
  • PAGES：180
  • REPORT CODE：GMM645626
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biologics & Biosimilars is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Biologics & Biosimilars market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Biologics & Biosimilars industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Biologics & Biosimilars Market Segmentations:

    By Players:

    • AbbVie

    • Sanofi

    • Gelgen Biopharma

    • Roche

    • Hospira

    • Amgen

    • Merck

    • Johnson & Johnson

    • Changchun High Tech

    • Sandoz

    • CP Guojian Pharmacy

    • Novo Nordisk

    • Mylan

    • Lilly

    • Novartis

    • Biotech Pharma

    • Teva

    • 3sbio

    • fizer

    By Types:

    • Antibiotic

    • Enzyme

    • Hormone

    • Non-Patented Biological Reagents

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics & Biosimilars Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Biologics & Biosimilars Market Size and Growth Rate of Antibiotic from 2014 to 2026

      • 1.3.2 Global Biologics & Biosimilars Market Size and Growth Rate of Enzyme from 2014 to 2026

      • 1.3.3 Global Biologics & Biosimilars Market Size and Growth Rate of Hormone from 2014 to 2026

      • 1.3.4 Global Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents from 2014 to 2026

      • 1.3.5 Global Biologics & Biosimilars Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Biologics & Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

      • 1.4.2 Global Biologics & Biosimilars Market Size and Growth Rate of Diabetes from 2014 to 2026

      • 1.4.3 Global Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

      • 1.4.4 Global Biologics & Biosimilars Market Size and Growth Rate of Hemophilia from 2014 to 2026

      • 1.4.5 Global Biologics & Biosimilars Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Biologics & Biosimilars Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biologics & Biosimilars Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biologics & Biosimilars by Major Types

      • 3.4.1 Biologics & Biosimilars Market Size and Growth Rate of Antibiotic

      • 3.4.2 Biologics & Biosimilars Market Size and Growth Rate of Enzyme

      • 3.4.3 Biologics & Biosimilars Market Size and Growth Rate of Hormone

      • 3.4.4 Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents

      • 3.4.5 Biologics & Biosimilars Market Size and Growth Rate of Other

    4 Segmentation of Biologics & Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biologics & Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biologics & Biosimilars in Tumor

      • 4.4.2 Market Size and Growth Rate of Biologics & Biosimilars in Diabetes

      • 4.4.3 Market Size and Growth Rate of Biologics & Biosimilars in Cardiovascular

      • 4.4.4 Market Size and Growth Rate of Biologics & Biosimilars in Hemophilia

      • 4.4.5 Market Size and Growth Rate of Biologics & Biosimilars in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Biologics & Biosimilars Production Analysis by Major Regions

    • 5.2 Global Biologics & Biosimilars Consumption Analysis by Major Regions

    • 5.3 Global Biologics & Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Biologics & Biosimilars Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Biologics & Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Biologics & Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Biologics & Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Commodity of Biologics & Biosimilars Market in Major Countries

    • 6.1 Top 5 Export Countries in Biologics & Biosimilars market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Biologics & Biosimilars market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Biologics & Biosimilars market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biologics & Biosimilars market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Biologics & Biosimilars market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Biologics & Biosimilars market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Biologics & Biosimilars Landscape Analysis

    • 7.1 North America Biologics & Biosimilars Landscape Analysis by Major Types

    • 7.2 North America Biologics & Biosimilars Landscape Analysis by Major End-Users

    • 7.3 North America Biologics & Biosimilars Landscape Analysis by Major Countries

      • 7.3.1 United States Biologics & Biosimilars Market Volume and Growth Rate

      • 7.3.2 Canada Biologics & Biosimilars Market Volume and Growth Rate

      • 7.3.3 Mexico Biologics & Biosimilars Market Volume and Growth Rate

    8 Europe Biologics & Biosimilars Landscape Analysis

    • 8.1 Europe Biologics & Biosimilars Landscape Analysis by Major Types

    • 8.2 Europe Biologics & Biosimilars Landscape Analysis by Major End-Users

    • 8.3 Europe Biologics & Biosimilars Landscape Analysis by Major Countries

      • 8.3.1 Germany Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.2 UK Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.3 France Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.4 Italy Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.6 Spain Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.7 Belgium Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.8 Poland Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.9 Russia Biologics & Biosimilars Market Volume and Growth Rate

      • 8.3.10 Turkey Biologics & Biosimilars Market Volume and Growth Rate

    9 Asia Pacific Biologics & Biosimilars Landscape Analysis

    • 9.1 Asia Pacific Biologics & Biosimilars Landscape Analysis by Major Types

    • 9.2 Asia Pacific Biologics & Biosimilars Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Biologics & Biosimilars Landscape Analysis by Major Countries

      • 9.3.1 China Biologics & Biosimilars Market Volume and Growth Rate

      • 9.3.2 Japan Biologics & Biosimilars Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Biologics & Biosimilars Market Volume and Growth Rate

      • 9.3.4 India Biologics & Biosimilars Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Biologics & Biosimilars Market Volume and Growth Rate

      • 9.3.6 South Korea Biologics & Biosimilars Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Biologics & Biosimilars Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Biologics & Biosimilars Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Biologics & Biosimilars Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Biologics & Biosimilars Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Biologics & Biosimilars Market Volume and Growth Rate

      • 10.3.2 Brazil Biologics & Biosimilars Market Volume and Growth Rate

      • 10.3.3 Nigeria Biologics & Biosimilars Market Volume and Growth Rate

      • 10.3.4 South Africa Biologics & Biosimilars Market Volume and Growth Rate 

      • 10.3.5 Argentina Biologics & Biosimilars Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 AbbVie

      • 11.1.1 AbbVie Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Gelgen Biopharma

      • 11.3.1 Gelgen Biopharma Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Roche

      • 11.4.1 Roche Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Hospira

      • 11.5.1 Hospira Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Amgen

      • 11.6.1 Amgen Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Merck

      • 11.7.1 Merck Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Johnson & Johnson

      • 11.8.1 Johnson & Johnson Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Changchun High Tech

      • 11.9.1 Changchun High Tech Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Sandoz

      • 11.10.1 Sandoz Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 CP Guojian Pharmacy

      • 11.11.1 CP Guojian Pharmacy Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Novo Nordisk

      • 11.12.1 Novo Nordisk Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Mylan

      • 11.13.1 Mylan Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Lilly

      • 11.14.1 Lilly Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Novartis

      • 11.15.1 Novartis Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Biotech Pharma

      • 11.16.1 Biotech Pharma Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Teva

      • 11.17.1 Teva Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 3sbio

      • 11.18.1 3sbio Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 fizer

      • 11.19.1 fizer Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 81 Figures and 205 Tables)

    • Figure Product Picture

    • Figure Biologics & Biosimilars Market Size and Growth Rate of Antibiotic from 2014 to 2026

    • Figure Biologics & Biosimilars Market Size and Growth Rate of Enzyme from 2014 to 2026

    • Figure Biologics & Biosimilars Market Size and Growth Rate of Hormone from 2014 to 2026

    • Figure Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents from 2014 to 2026

    • Figure Biologics & Biosimilars Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Biologics & Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

    • Figure Global Biologics & Biosimilars Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Global Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • Figure Global Biologics & Biosimilars Market Size and Growth Rate of Hemophilia from 2014 to 2026

    • Figure Global Biologics & Biosimilars Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Biologics & Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biologics & Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biologics & Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biologics & Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Biologics & Biosimilars by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Antibiotic

    • Figure Market Size and Growth Rate of Enzyme

    • Figure Market Size and Growth Rate of Hormone

    • Figure Market Size and Growth Rate of Non-Patented Biological Reagents

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biologics & Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biologics & Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of Hemophilia

    • Figure Market Size and Growth Rate of Other

    • Table Global Biologics & Biosimilars Production by Major Regions

    • Table Global Biologics & Biosimilars Production Share by Major Regions

    • Figure Global Biologics & Biosimilars Production Share by Major Regions in 2014

    • Figure Global Biologics & Biosimilars Production Share by Major Regions in 2018

    • Figure Global Biologics & Biosimilars Production Share by Major Regions in 2026

    • Table Global Biologics & Biosimilars Consumption by Major Regions

    • Table Global Biologics & Biosimilars Consumption Share by Major Regions

    • Figure Global Biologics & Biosimilars Consumption Share by Major Regions in 2014

    • Figure Global Biologics & Biosimilars Consumption Share by Major Regions in 2018

    • Figure Global Biologics & Biosimilars Consumption Share by Major Regions in 2026

    • Table North America Biologics & Biosimilars Production, Import, Consumption and Export Analysis

    • Table Europe Biologics & Biosimilars Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Biologics & Biosimilars Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biologics & Biosimilars market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biologics & Biosimilars market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biologics & Biosimilars market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biologics & Biosimilars market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Biologics & Biosimilars Consumption by Types from 2014 to 2026

    • Table North America Biologics & Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure North America Biologics & Biosimilars Consumption Share by Types in 2014

    • Figure North America Biologics & Biosimilars Consumption Share by Types in 2018

    • Figure North America Biologics & Biosimilars Consumption Share by Types in 2026

    • Table North America Biologics & Biosimilars Consumption by End-Users from 2014 to 2026

    • Table North America Biologics & Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure North America Biologics & Biosimilars Consumption Share by End-Users in 2014

    • Figure North America Biologics & Biosimilars Consumption Share by End-Users in 2018

    • Figure North America Biologics & Biosimilars Consumption Share by End-Users in 2026

    • Table North America Biologics & Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table North America Biologics & Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Biologics & Biosimilars Consumption Share by Major Countries in 2014

    • Figure North America Biologics & Biosimilars Consumption Share by Major Countries in 2018

    • Figure North America Biologics & Biosimilars Consumption Share by Major Countries in 2026

    • Figure United States Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Biologics & Biosimilars Consumption by Types from 2014 to 2026

    • Table Europe Biologics & Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Europe Biologics & Biosimilars Consumption Share by Types in 2014

    • Figure Europe Biologics & Biosimilars Consumption Share by Types in 2018

    • Figure Europe Biologics & Biosimilars Consumption Share by Types in 2026

    • Table Europe Biologics & Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Europe Biologics & Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Biologics & Biosimilars Consumption Share by End-Users in 2014

    • Figure Europe Biologics & Biosimilars Consumption Share by End-Users in 2018

    • Figure Europe Biologics & Biosimilars Consumption Share by End-Users in 2026

    • Table Europe Biologics & Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Europe Biologics & Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Biologics & Biosimilars Consumption Share by Major Countries in 2014

    • Figure Europe Biologics & Biosimilars Consumption Share by Major Countries in 2018

    • Figure Europe Biologics & Biosimilars Consumption Share by Major Countries in 2026

    • Figure Germany Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure France Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Biologics & Biosimilars Consumption by Types from 2014 to 2026

    • Table Asia Pacific Biologics & Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by Types in 2014

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by Types in 2018

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by Types in 2026

    • Table Asia Pacific Biologics & Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Biologics & Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by End-Users in 2014

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by End-Users in 2018

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by End-Users in 2026

    • Table Asia Pacific Biologics & Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Biologics & Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Biologics & Biosimilars Consumption Share by Major Countries in 2026

    • Figure China Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandBiologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure India Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Biologics & Biosimilars Consumption Share by Major Countries in 2026

    • Figure GCC Countries Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Biologics & Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Gelgen Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen Biopharma

    • Figure Sales and Growth Rate Analysis of Gelgen Biopharma

    • Figure Revenue and Market Share Analysis of Gelgen Biopharma

    • Table Product and Service Introduction of Gelgen Biopharma

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Changchun High Tech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech

    • Figure Sales and Growth Rate Analysis of Changchun High Tech

    • Figure Revenue and Market Share Analysis of Changchun High Tech

    • Table Product and Service Introduction of Changchun High Tech

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of CP Guojian Pharmacy

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian Pharmacy

    • Figure Sales and Growth Rate Analysis of CP Guojian Pharmacy

    • Figure Revenue and Market Share Analysis of CP Guojian Pharmacy

    • Table Product and Service Introduction of CP Guojian Pharmacy

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly

    • Figure Sales and Growth Rate Analysis of Lilly

    • Figure Revenue and Market Share Analysis of Lilly

    • Table Product and Service Introduction of Lilly

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Biotech Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech Pharma

    • Figure Sales and Growth Rate Analysis of Biotech Pharma

    • Figure Revenue and Market Share Analysis of Biotech Pharma

    • Table Product and Service Introduction of Biotech Pharma

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of 3sbio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio

    • Figure Sales and Growth Rate Analysis of 3sbio

    • Figure Revenue and Market Share Analysis of 3sbio

    • Table Product and Service Introduction of 3sbio

    • Table Company Profile and Development Status of fizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of fizer

    • Figure Sales and Growth Rate Analysis of fizer

    • Figure Revenue and Market Share Analysis of fizer

    • Table Product and Service Introduction of fizer


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US